When cells go about the business of dividing, they can get sidelined. Maybe there aren’t enough nutrients. Maybe there aren’t the right signals to resume multiplying. Either way, cells go quiet.
Loren Miller, M.D., M.P.H. has found no reliable epidemiological or clinical risk factors that could distinguish patients with CA-MRSA infection from patients with CA-MSSA infection. “What this means,” says Dr. Miller, “is that the average Joe or Jane can get CA-MRSA.”
Chinese HIV/AIDS advocate and retired physician Gao Yaojie last week was put under house arrest by Chinese authorities to prevent her from visiting the U.S. next month to accept an award from the group Vital Voices Global Partnership.
Mayo Clinic surgeons have proposed a system of lung surgery quality indicators for surgeons and the public as a method to demonstrate best practices for obtaining positive patient outcomes.
For many women, irregular or infrequent menstrual cycles may not sound like such a bad thing. But a condition that can cause irregular periods ? polycystic ovary syndrome, or PCOS ? can present women with numerous health concerns, ranging from excess hair growth to fertility issues to an increased risk of heart disease and diabetes.
Most (64 percent of Americans, according to one recent study) are satisfied with their sex lives.
Active patient involvement during treatment of chronic heart failure, coupled with partnership with healthcare team members to provide care consistent with evidence-based guidelines, dramatically improves quality of care for chronic heart failure patients.
A research team led by Prof. Claude Perreault, Universit? de Montr?al, is announcing a major discovery in Genomics. This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts.
A study published in the February 1st issue of the journal Sleep finds that parasomnias in children are common, and often more frequent than in adults.
HIV prevention advocates from three major civil society organizations today emphasized the importance of continued research into new HIV prevention options, despite the recent discontinuation of the phase III effectiveness trials of the microbicide candidate, cellulose sulfate (CS).